"With U.K. data showing that people infected with both COVID-19 and the flu are more than five times as likely to die compared to someone with no infection1, it is more important than ever to consider any vaccine offered to you by the National Health Service," said Stanley C. Erck, President and Chief Executive Officer, Novavax. "We continue to believe in the importance of a diversified national vaccine portfolio to reduce winter pressures on the health service."